Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diagnostic Imaging. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107163022B discloses novel isoquinoline compounds for Alzheimer's diagnosis. We offer scalable synthesis and reliable supply chain solutions.
Patent CN100418966C details a novel synthesis for long-half-life PBR imaging agents, offering reliable supply and cost reduction in PET tracer manufacturing.
Advanced synthesis of low-osmolarity triiodobenzene compounds for X-ray imaging. Discover cost-effective manufacturing and supply chain solutions for high-purity contrast agents.
Novel triiodo-benzene synthesis reduces osmotic pressure. Reliable pharmaceutical intermediate supplier offering cost-effective scaling.
Patent CN1166649C reveals an aqueous synthesis route for Gadoteridol intermediates, offering safer manufacturing and reduced environmental impact for pharmaceutical supply chains.
Novel purification method for Iopromide using diacetoxy intermediate removes byproducts efficiently, ensuring high yield and pharmaceutical grade purity for contrast agents.
Patent CN113717067A details a novel synthesis for diiodoisophthaloyl chloride impurities, enabling superior quality control and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102548956B details a novel Stevens rearrangement process for high-purity DTPA derivatives, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN103739635A reveals a novel recrystallization method for 1,3,4,6-tetra-O-acetyl-beta-D-mannopyranose, significantly boosting yield and purity for reliable 18F-FDG production.